{ "agent_instructions": "This is a Vislumbra Audit Brief for an AI coding agent. Every item in \"findings\" (inside each page of \"pages\") describes a change that is feasible WITHOUT adding any component that does not already exist on the page identified by \"url\". STEP 1: scan all findings where pass=false and blocker is \"asset\" or \"confirm\", and list these as a short set of questions for the user BEFORE changing anything (\"asset\" = you need a file/photo/logo/quote from them; \"confirm\" = the fix would change what type an element is, e.g. video to image, not just restyle it). STEP 2: apply every remaining finding where pass=false and blocker is null, without asking, in priority order (week before month). Before applying a finding, check whether it is already implemented in the code but just not visually prominent, since screenshot-based audits can miss that. Locate the relevant markup/CSS yourself in the target repo; this file does not include code, only the specification of what \"done\" looks like.", "site": "ozemback.com", "generated_at": "2026-07-14T17:16:37+00:00", "pages": [ { "page": "Home", "url": "https://ozemback.com", "score_today": 71, "score_after_fixes": 89, "priority_summary": [ { "title": "Name real authors with credentials on essays", "why": "The essays make specific science claims (like GLP-1 receptor effects) but are only credited to 'Ozemback Editorial,' which weakens reader trust and hurts how Google and AI tools rank health-adjacent content." }, { "title": "Add photos to the story preview cards", "why": "Every 'Recent stories' card is plain text with no image, which makes a magazine site feel flat and less inviting to click into." }, { "title": "Give the newsletter form real, permanent field labels", "why": "The name and email boxes only show placeholder text that vanishes once someone starts typing, which is a known accessibility problem for screen reader and low-vision users." } ], "findings": [ { "pillar": "Photos & Images", "task": "Add a photo or visual to each of the four 'Recent stories' cards", "why": "Right now the story grid is text-only, which makes the page feel less like a real magazine and less scannable for readers deciding what to read.", "priority": "week", "pass": false, "blocker": "asset", "source": "content engagement / visual scanning" }, { "pillar": "Photos & Images", "task": "Add descriptive alt text to the featured essay photo of the woman reading", "why": "Screen reader users currently have no way to know what this image shows unless alt text is written for it.", "priority": "week", "pass": false, "blocker": "null", "source": "WCAG 1.1.1 non-text content" }, { "pillar": "Photos & Images", "task": "Keep the warm, editorial tone of the one photo used", "why": "The featured essay photo is high quality and matches the reflective, literary voice of the brand well.", "priority": "good", "pass": true, "blocker": null, "source": "brand consistency" }, { "pillar": "Buttons & Actions", "task": "Confirm and clarify where the header 'Subscribe' button goes", "why": "It sits next to nav items like a paid action, but the only visible subscription on the page is a free monthly newsletter \u2014 readers may expect something different.", "priority": "month", "pass": false, "blocker": "confirm", "source": "CTA intent clarity" }, { "pillar": "Buttons & Actions", "task": "Keep the consistent orange arrow style on 'Read the essay' and 'Read more' links", "why": "Using the same color and arrow icon for every article link makes it instantly clear what's clickable across the whole page.", "priority": "good", "pass": true, "blocker": null, "source": "interaction consistency" }, { "pillar": "Buttons & Actions", "task": "Keep the high-contrast lime-green 'Subscribe' button in the newsletter block", "why": "It stands out clearly against the dark green background, making the main email signup easy to find.", "priority": "good", "pass": true, "blocker": null, "source": "contrast / CTA visibility" }, { "pillar": "Layout & Structure", "task": "Trim the repeated 'not medical advice / not affiliated' disclaimer that appears near-identically three times (hero, manifesto, footer)", "why": "Repeating the exact same sentence three times can feel redundant to readers and weakens the impact of the one that matters most in the footer.", "priority": "month", "pass": false, "blocker": "null", "source": "content redundancy" }, { "pillar": "Layout & Structure", "task": "Keep the alternating cream/beige/dark-green section backgrounds", "why": "This creates clear visual breaks between the hero, manifesto, stories, newsletter, and footer sections, helping readers know where one topic ends and the next begins.", "priority": "good", "pass": true, "blocker": null, "source": "visual rhythm" }, { "pillar": "Words on the Page", "task": "Replace the generic 'BY OZEMBACK EDITORIAL' byline with a named writer or contributor bio where possible", "why": "A named author with relevant background builds more trust than an anonymous 'editorial' credit, especially for content that touches on medication and science.", "priority": "week", "pass": false, "blocker": "asset", "source": "author trust signals" }, { "pillar": "Words on the Page", "task": "Add a visible source or citation next to specific claims like 'GLP-1 receptors are densely expressed in reward circuits'", "why": "Stating a precise physiological claim without a visible source raises legal exposure even on a site that positions itself as cultural commentary, not medical advice.", "priority": "week", "pass": false, "blocker": "asset", "source": "YMYL claim substantiation" }, { "pillar": "Words on the Page", "task": "Keep the manifesto's clear statement of what the magazine is and isn't (not a clinic, no protocols sold)", "why": "This upfront honesty about the site's purpose is exactly what builds reader trust and reduces confusion about intent.", "priority": "good", "pass": true, "blocker": null, "source": "positioning clarity" }, { "pillar": "Menu & Getting Around", "task": "Use matching wording for the 'STORIES' nav link and the 'ALL STORIES' link so readers know they lead to the same place", "why": "Slightly different labels for what is likely the same destination can create small moments of doubt while browsing.", "priority": "month", "pass": false, "blocker": "null", "source": "navigation labeling consistency" }, { "pillar": "Menu & Getting Around", "task": "Keep the short, matching header and footer navigation (Stories, About, Legal, Contact)", "why": "Having the same core links in both places makes the site easy to navigate no matter where a reader is on the page.", "priority": "good", "pass": true, "blocker": null, "source": "navigation redundancy best practice" }, { "pillar": "Being Found by AI & Google", "task": "Add a visible publish or last-updated date to each story card", "why": "Search engines and AI tools use freshness dates to judge how current cultural commentary is; none of the individual story previews show one.", "priority": "month", "pass": false, "blocker": "asset", "source": "content freshness signals" }, { "pillar": "Being Found by AI & Google", "task": "Add named author credentials across essays discussing health-adjacent topics", "why": "Google and AI answer engines weigh expertise and authorship more heavily for topics that touch health, even when framed as cultural writing.", "priority": "week", "pass": false, "blocker": "asset", "source": "E-E-A-T / YMYL guidance" }, { "pillar": "Being Found by AI & Google", "task": "Keep the clear, specific hero headline ('The body conversation has a third way')", "why": "A distinct, quotable headline gives search engines and AI tools a strong, unique topic signal to associate with the site.", "priority": "good", "pass": true, "blocker": null, "source": "headline clarity for indexing" }, { "pillar": "Legal & Accessibility Risk", "task": "Add permanent visible labels above the 'First name' and email fields in the newsletter form, not just placeholder text", "why": "Placeholder-only fields disappear once someone starts typing, which fails accessibility guidance and can confuse screen reader users.", "priority": "week", "pass": false, "blocker": "null", "source": "WCAG 3.3.2 labels or instructions" }, { "pillar": "Legal & Accessibility Risk", "task": "Check and increase contrast on the small gray disclaimer and fine-print text on cream backgrounds", "why": "Light gray text on a pale cream background may be too low-contrast for readers with low vision to read comfortably.", "priority": "week", "pass": false, "blocker": "null", "source": "WCAG 1.4.3 contrast minimum" }, { "pillar": "Legal & Accessibility Risk", "task": "Add a visible citation for the GLP-1 receptor claim in the featured essay teaser", "why": "Making a specific physiological claim without a source increases legal exposure even when the site disclaims itself as non-medical.", "priority": "week", "pass": false, "blocker": "asset", "source": "claim substantiation risk" }, { "pillar": "Legal & Accessibility Risk", "task": "Keep the repeated 'not medical advice / not affiliated' disclaimers and proper trademark attribution in the footer", "why": "Clearly and repeatedly stating the site is not medical advice and not affiliated with any pharmaceutical company, plus correctly crediting trademarks, shows strong legal diligence.", "priority": "good", "pass": true, "blocker": null, "source": "disclaimer and trademark best practice" } ], "executive_summary": "Ozemback scores 71/100 today: the writing, disclaimers, and overall layout are thoughtfully built, but the page is missing the kind of trust and visual signals that turn casual readers into subscribers. The three biggest wins are naming real authors with credentials on essays that make health-related claims (right now everything is credited to 'Ozemback Editorial'), adding photos to the story preview cards so the page feels like a real magazine instead of a text list, and fixing the newsletter signup form so its name and email fields have permanent labels instead of disappearing placeholder text. None of these require rebuilding the site \u2014 they're refinements to what's already there \u2014 and addressing them should lift the score to roughly 89/100." }, { "page": "Blog", "url": "https://ozemback.com/blog", "score_today": 66, "score_after_fixes": 84, "priority_summary": [ { "title": "Make the medical disclaimer visible, not just footer fine print", "why": "The only 'this isn't medical advice' text is tiny gray copy at the very bottom, which is risky when every article discusses real drugs, dosing, and FDA/DEA action." }, { "title": "Add a photo or thumbnail to every story card", "why": "Only the featured essay has an image \u2014 the other 9 story cards are pure text blocks, which makes the archive feel flat and reduces clicks." }, { "title": "Turn 'Read the essay' into a real button", "why": "The only CTA on the page besides Subscribe is a plain underlined text link, so the featured story's next step doesn't stand out." } ], "findings": [ { "pillar": "Photos & Images", "task": "Add a photo/thumbnail to each of the 12 story cards in the 'All stories' grid", "why": "Right now only the top featured essay has an image; every other card is text-only, which makes scanning the archive feel monotonous and less inviting to click.", "priority": "month", "pass": false, "blocker": "asset", "source": "visual hierarchy / scannability" }, { "pillar": "Photos & Images", "task": "Confirm the featured hero photo has descriptive alt text", "why": "Screen reader users and Google image search both rely on alt text, and there's no visible caption to confirm one exists.", "priority": "week", "pass": false, "blocker": null, "source": "WCAG 1.1.1 alt text" }, { "pillar": "Photos & Images", "task": "Keep using one strong, well-composed lifestyle photo for the featured story", "why": "The reading-by-the-window photo is warm, on-brand, and clearly tied to the essay topic.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Buttons & Actions", "task": "Restyle 'Read the essay' as a filled or outlined button instead of a plain underlined link", "why": "It's the main call-to-action for the top featured story, but it currently looks the same weight as a footnote.", "priority": "week", "pass": false, "blocker": null, "source": "CTA contrast/affordance" }, { "pillar": "Buttons & Actions", "task": "Add a visible 'Read more' label or arrow to each of the 12 story cards", "why": "Right now it's not obvious the whole card is clickable \u2014 visitors may not realize they can open the full article.", "priority": "month", "pass": false, "blocker": null, "source": "click affordance" }, { "pillar": "Buttons & Actions", "task": "Keep the 'Subscribe to the letter' button high-contrast and centered in the footer band", "why": "Bright green on dark green with clear spacing makes it the easiest thing to find on the whole page.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Buttons & Actions", "task": "Verify the ES language toggle actually switches content, not just a dead link", "why": "If Spanish content doesn't exist yet, offering the toggle without it will frustrate visitors and looks broken.", "priority": "week", "pass": false, "blocker": "confirm", "source": "functional link check" }, { "pillar": "Layout & Structure", "task": "Add a 'load more' or pagination control at the bottom of the story grid", "why": "The archive stops abruptly right into the footer with no way to see older stories beyond what's shown.", "priority": "month", "pass": false, "blocker": "confirm", "source": "content discoverability" }, { "pillar": "Layout & Structure", "task": "Keep the consistent 3-column card grid with matching spacing for tags, title, excerpt, and date", "why": "Every story card follows the same clean pattern, which makes the archive easy to scan.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Words on the Page", "task": "Add an author name or byline to each article/card", "why": "For content about medications, FDA actions, and clinical trials, showing who wrote it builds trust that anonymous text can't.", "priority": "month", "pass": false, "blocker": "asset", "source": "E-E-A-T trust signal" }, { "pillar": "Words on the Page", "task": "Make the hero subheading mention the core topic (GLP-1/Ozempic) instead of only 'personal essays'", "why": "The current tagline is generic and doesn't tell new visitors what the site actually covers at a glance.", "priority": "week", "pass": false, "blocker": null, "source": "clarity/SEO relevance" }, { "pillar": "Words on the Page", "task": "Keep the consistent category tagging style (Analysis \u00b7 Market & Pricing, etc.)", "why": "Clear topic labels above each headline make it fast to tell what kind of piece you're about to read.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Menu & Getting Around", "task": "Add a way to filter or search the story archive by the existing category tags", "why": "There are already several repeated categories (Market & Pricing, Regulatory + Policy, Clinical Data) but no way to click a tag and see just that group.", "priority": "month", "pass": false, "blocker": "confirm", "source": "faceted navigation" }, { "pillar": "Menu & Getting Around", "task": "Keep matching Home/Stories/About/Legal/Contact links in both header and footer", "why": "Having the same core navigation repeated at the bottom makes it easy to move around after a long scroll.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Being Found by AI & Google", "task": "Rewrite the main H1 to include the site's real subject (GLP-1/Ozempic culture) rather than the generic 'Cultural reportage and personal essays'", "why": "Search engines weigh the main headline heavily, and right now it doesn't say what topic the site actually covers.", "priority": "week", "pass": false, "blocker": null, "source": "on-page SEO / H1 relevance" }, { "pillar": "Being Found by AI & Google", "task": "Add visible publish dates and authors consistently to every article, not just some", "why": "Freshness and authorship are signals AI and Google use to trust health-adjacent content; dates are shown but authors are missing everywhere.", "priority": "month", "pass": false, "blocker": "asset", "source": "YMYL/E-E-A-T signals" }, { "pillar": "Being Found by AI & Google", "task": "Good use of specific, descriptive headlines with real numbers (e.g. '6.5 points', '$499')", "why": "Specific, factual headlines tend to perform well in both search and AI summarization.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Legal & Accessibility Risk", "task": "Move the 'Not medical advice \u2014 a cultural conversation' disclaimer higher up, near the featured essay or top of the story grid, not only in the small footer copyright line", "why": "Given every article discusses real drugs, dosing, and regulatory news, burying the disclaimer at the very bottom is a real liability and trust risk.", "priority": "week", "pass": false, "blocker": null, "source": "YMYL disclosure placement" }, { "pillar": "Legal & Accessibility Risk", "task": "Increase contrast/size of the footer disclaimer text", "why": "It's currently small light-gray text on a dark green background, which is hard to read and may not meet accessibility contrast minimums.", "priority": "week", "pass": false, "blocker": null, "source": "WCAG 1.4.3 contrast" }, { "pillar": "Legal & Accessibility Risk", "task": "Confirm whether a cookie/privacy consent notice is required given the ES/EN toggle suggesting international visitors", "why": "If European visitors are targeted, a missing consent banner could be a compliance gap; this isn't visible anywhere in the page.", "priority": "month", "pass": false, "blocker": "confirm", "source": "GDPR cookie consent" } ], "executive_summary": "This blog page scores 66/100 today: it's well-organized and on-brand, but has a few fixable gaps. The biggest issue is that the 'not medical advice' disclaimer only appears as tiny gray text at the very bottom of the page, which is a real risk given every article discusses actual medications, FDA decisions, and dosing. Second, only the top featured story has a photo \u2014 the other 12 articles are plain text cards, which flattens the browsing experience. Third, the main call-to-action ('Read the essay') is just an underlined link instead of a real button, so it doesn't stand out. Fixing these three things \u2014 surfacing the disclaimer, adding thumbnails to story cards, and strengthening the CTA button \u2014 could realistically push the score to around 84." }, { "page": "About", "url": "https://ozemback.com/about", "score_today": 74, "score_after_fixes": 89, "priority_summary": [ { "title": "Turn 'Subscribe' into a real button", "why": "Right now it sits as plain text in the menu next to 'About' and 'Legal', so visitors don't realize it's the one action you actually want them to take." }, { "title": "Fix low-contrast text in links and footer", "why": "The orange links on the cream background and the pale gray copyright line in the footer are hard to read and risk failing accessibility standards." }, { "title": "Add a human face or team credential to the About page", "why": "A page that explains 'who we are' with zero photos or bylines makes it harder for readers (and Google) to trust the people behind the magazine." } ], "findings": [ { "pillar": "Photos & Images", "task": "Add at least one real photo (founder, editorial team, or a relevant cultural image) to the About page", "why": "An about page with only text makes the magazine feel anonymous and less trustworthy, especially for a sensitive health-adjacent topic.", "priority": "month", "pass": false, "blocker": "asset", "source": "trust signals / E-E-A-T for about pages" }, { "pillar": "Photos & Images", "task": "No images means no risk of missing alt-text", "why": "Since there are no images on the page at all, there's currently no accessibility debt from unlabeled photos.", "priority": "good", "pass": true, "blocker": null, "source": "WCAG 1.1.1 non-text content" }, { "pillar": "Buttons & Actions", "task": "Style 'Subscribe' in the header as a visually distinct button, not a plain nav link", "why": "It currently looks identical to 'About' and 'Legal', so readers don't notice it's the main thing you want them to click.", "priority": "week", "pass": false, "blocker": null, "source": "primary CTA visual weight" }, { "pillar": "Buttons & Actions", "task": "Style the contact email (info@ozemback.com) as a button or highlighted contact card", "why": "A plain inline text link is easy to miss for readers who want to pitch a story or write in.", "priority": "month", "pass": false, "blocker": null, "source": "affordance clarity" }, { "pillar": "Buttons & Actions", "task": "Language toggle (EN/ES) is simple and clearly placed", "why": "It's easy to find in the top corner and doesn't compete with other actions.", "priority": "good", "pass": true, "blocker": null, "source": "consistent nav placement" }, { "pillar": "Layout & Structure", "task": "Heading hierarchy is clear and consistent (About > A magazine for the reflective middle > section heads)", "why": "Readers and search engines can easily tell what each section is about.", "priority": "good", "pass": true, "blocker": null, "source": "H1/H2 structure" }, { "pillar": "Layout & Structure", "task": "The pulled quote block is visually separated with a colored border", "why": "It breaks up long text and highlights the most important line on the page.", "priority": "good", "pass": true, "blocker": null, "source": "visual hierarchy / blockquote styling" }, { "pillar": "Layout & Structure", "task": "Break up the long opening paragraphs ('We started Ozemback because...') with a subhead or pull-quote", "why": "Two dense paragraphs in a row before the first section heading make readers skim past key points.", "priority": "month", "pass": false, "blocker": null, "source": "text chunking for scannability" }, { "pillar": "Words on the Page", "task": "Mission statement is clear, confident, and specific ('a magazine for the reflective middle')", "why": "It immediately tells readers what the publication is for and who it's not for.", "priority": "good", "pass": true, "blocker": null, "source": "clarity of value proposition" }, { "pillar": "Words on the Page", "task": "'What we are' / 'What we are not' framing is a strong, scannable contrast", "why": "It removes ambiguity fast, which matters for a topic surrounded by scams and misinformation.", "priority": "good", "pass": true, "blocker": null, "source": "content structure" }, { "pillar": "Words on the Page", "task": "Add one closing line near the bottom nudging readers toward subscribing or reading a story", "why": "The page ends on legal disclaimer language with no soft invitation to do anything next.", "priority": "month", "pass": false, "blocker": null, "source": "closing CTA copy" }, { "pillar": "Menu & Getting Around", "task": "Header and footer navigation match and stay consistent", "why": "Readers can always find Stories, About, Legal, and Subscribe no matter where they are on the page.", "priority": "good", "pass": true, "blocker": null, "source": "consistent global nav" }, { "pillar": "Menu & Getting Around", "task": "Confirm whether a search or filter exists for the Stories section and surface it from here if so", "why": "A reader who wants to explore past essays has no visible way to search or browse topics from this page.", "priority": "month", "pass": false, "blocker": "confirm", "source": "findability of archive content" }, { "pillar": "Being Found by AI & Google", "task": "Page content directly and explicitly explains what the site is and isn't", "why": "This kind of plain-language self-description is exactly what AI answer engines and Google favor when summarizing a brand.", "priority": "good", "pass": true, "blocker": null, "source": "explicit entity definition for LLM answer engines" }, { "pillar": "Being Found by AI & Google", "task": "Add named bylines, credentials, or an editorial team bio linked from this page", "why": "Google and AI tools weigh 'who wrote this' heavily for health-adjacent topics, and right now there's no named author or team anywhere.", "priority": "week", "pass": false, "blocker": "asset", "source": "E-E-A-T authorship signals" }, { "pillar": "Being Found by AI & Google", "task": "Link to the Stories archive or a sitemap from this page", "why": "Right now the About page is a dead end that doesn't route readers or crawlers deeper into the site's content.", "priority": "month", "pass": false, "blocker": null, "source": "internal linking for crawlability" }, { "pillar": "Legal & Accessibility Risk", "task": "Medical disclaimer section is explicit, thorough, and clearly separates content from medical advice", "why": "This is exactly the kind of clear disclaimer needed for a publication covering medication topics.", "priority": "good", "pass": true, "blocker": null, "source": "editorial/medical disclaimer best practice" }, { "pillar": "Legal & Accessibility Risk", "task": "Footer clearly states no pharmaceutical affiliation", "why": "This protects the brand from being mistaken for a sponsored or clinical source.", "priority": "good", "pass": true, "blocker": null, "source": "disclosure transparency" }, { "pillar": "Legal & Accessibility Risk", "task": "Increase contrast on footer copyright text (pale gray on dark green)", "why": "That text is hard to read for many users and likely fails minimum contrast guidelines.", "priority": "week", "pass": false, "blocker": null, "source": "WCAG 1.4.3 contrast minimum" }, { "pillar": "Legal & Accessibility Risk", "task": "Check contrast of orange body-text links (e.g. email address, 'Legal & Disclaimer') against the cream background", "why": "Orange-on-cream at small text sizes often falls below accessible contrast ratios, making links hard to read for low-vision users.", "priority": "week", "pass": false, "blocker": null, "source": "WCAG 1.4.3 contrast minimum" }, { "pillar": "Legal & Accessibility Risk", "task": "Add a skip-to-content link for keyboard and screen-reader users", "why": "The page has a long header and this would let assistive-technology users jump straight to the main content.", "priority": "month", "pass": false, "blocker": null, "source": "WCAG 2.4.1 bypass blocks" } ], "executive_summary": "This About page scores 74/100 today \u2014 the writing is clear, confident, and the medical/legal disclaimers are genuinely well done for a topic this sensitive. The three highest-value fixes are: make 'Subscribe' look like an actual button instead of blending into the menu, fix low-contrast text (the orange links and the pale footer copyright line) so it's easier to read, and add a real photo or named team bio so the page feels like it's written by real people rather than an anonymous account. None of these require new content systems \u2014 just restyling and small text additions \u2014 and doing them should push the score to roughly 89/100." }, { "page": "Blog Ozempic Personality What Science Says", "url": "https://ozemback.com/blog/ozempic-personality-what-science-says", "score_today": 64, "score_after_fixes": 85, "priority_summary": [ { "title": "Fix the broken sentences in the green callout boxes", "why": "Two bullet points have visible gaps where a word or phrase is missing, which makes the page look unfinished and confuses readers right at the top of the article." }, { "title": "Add a visible medical disclaimer", "why": "The article discusses medication side effects, mood changes, and suicidality data without a clear 'this is not medical advice' notice, which is a real legal exposure for health content." }, { "title": "Turn the cited studies into real links", "why": "Names like 'Klausen et al., 2022' and 'SELECT trial' are mentioned but not linked to a source, which weakens reader trust and hurts how credible AI tools and Google will rate this medical content." } ], "findings": [ { "pillar": "Photos & Images", "task": "Keep the lifestyle photo of the woman reading \u2014 it fits the calm, editorial tone well.", "why": "A relevant, well-lit photo at the top gives the article a human, trustworthy feel.", "priority": "good", "pass": true, "blocker": null, "source": "hero photograph, section 1" }, { "pillar": "Photos & Images", "task": "Add a simple diagram or chart to break up the science section (e.g. a brain-regions graphic near the VTA/nucleus accumbens/prefrontal cortex text).", "why": "A 13-minute read about brain chemistry with zero supporting visuals after the intro photo is harder to follow and skim.", "priority": "month", "pass": false, "blocker": "asset", "source": "no supporting visuals in sections 2-5" }, { "pillar": "Buttons & Actions", "task": "Style 'Subscribe' in the top navigation as an actual button (background color, contrast) instead of plain text next to Stories/About/Legal.", "why": "Right now Subscribe looks identical to the other menu links, so it doesn't stand out as the one action you actually want visitors to take.", "priority": "week", "pass": false, "blocker": null, "source": "header nav, section 1" }, { "pillar": "Buttons & Actions", "task": "Reuse the same 'Subscribe' styling to add one more subscribe prompt near the end of the article, after the FAQ.", "why": "A long, thoughtful health article is exactly the kind of content that earns a newsletter signup, but the only ask is buried in the top nav.", "priority": "month", "pass": false, "blocker": null, "source": "no mid/end-of-article CTA visible in sections 4-6" }, { "pillar": "Layout & Structure", "task": "Switch the justified text inside the dark-green 'Short Answer' and 'controlled-trial' callout boxes to left-aligned.", "why": "Justified text is stretching some lines and creating large empty gaps that look like missing words, hurting readability.", "priority": "week", "pass": false, "blocker": null, "source": "justified paragraph text, sections 1-2" }, { "pillar": "Layout & Structure", "task": "Add a simple in-page table of contents or jump links using the existing section headings (Where the term came from, The neuroscience..., What the evidence shows, etc.).", "why": "This is a 13-minute read with many sections; readers have no way to jump straight to the part they care about.", "priority": "month", "pass": false, "blocker": "confirm", "source": "no anchor navigation across sections 1-5" }, { "pillar": "Layout & Structure", "task": "Use clear H2/H3 structure throughout the piece.", "why": "Headings are consistent and scannable, which makes a long article easier to follow.", "priority": "good", "pass": true, "blocker": null, "source": "heading hierarchy, sections 2-5" }, { "pillar": "Words on the Page", "task": "Fill in the missing phrase in 'The consistent positive signal is ___:' and 'a constellation of ___ reported by patients' \u2014 both currently show an odd gap instead of text.", "why": "These read as broken or unfinished sentences, which undercuts the credibility of an otherwise carefully written piece.", "priority": "week", "pass": false, "blocker": "confirm", "source": "callout bullets, section 1 bottom and section 2 top" }, { "pillar": "Words on the Page", "task": "Hyperlink the named studies (Klausen et al. 2022, Aran\u00e4s et al. 2023, SELECT trial, FDA and EMA reviews) to their actual sources.", "why": "Naming studies without linking them makes claims hard to verify and looks less authoritative for a medical topic.", "priority": "week", "pass": false, "blocker": "asset", "source": "citations, section 3-4" }, { "pillar": "Words on the Page", "task": "Keep the FAQ section written as direct question-and-answer pairs.", "why": "Clear, plainly-worded questions and answers are easy for readers to scan and easy for search engines to quote.", "priority": "good", "pass": true, "blocker": null, "source": "FAQ section, section 6" }, { "pillar": "Menu & Getting Around", "task": "Add a breadcrumb trail (e.g. Stories > Neuroscience > this article) using the existing category tag.", "why": "Readers arriving from search have no quick way to see where this article sits in the site or browse the same category.", "priority": "month", "pass": false, "blocker": null, "source": "no breadcrumb near category tag, section 1" }, { "pillar": "Menu & Getting Around", "task": "Add a 'related articles' or 'read next' section at the very end of the piece.", "why": "The article ends after the FAQ with no path to keep reading, which loses engaged visitors right when they're most interested.", "priority": "month", "pass": false, "blocker": "confirm", "source": "no related-content links visible, section 6" }, { "pillar": "Menu & Getting Around", "task": "Keep the top navigation simple and consistent (Stories, About, Legal, Subscribe, language toggle).", "why": "A short, uncluttered main menu is easy to scan and understand at a glance.", "priority": "good", "pass": true, "blocker": null, "source": "header nav, section 1" }, { "pillar": "Being Found by AI & Google", "task": "Link the author byline 'Ozemback Editorial' to the existing About page and, if possible, note any medical reviewer.", "why": "For health topics, search engines and AI tools weigh author credibility heavily; right now the byline is just plain text with no way to check who wrote it.", "priority": "week", "pass": false, "blocker": null, "source": "byline, section 1" }, { "pillar": "Being Found by AI & Google", "task": "Add visible published/updated dates and a clear category tag.", "why": "These freshness and topic signals are already present and help both readers and search engines trust the content is current.", "priority": "good", "pass": true, "blocker": null, "source": "date/category metadata, section 1" }, { "pillar": "Being Found by AI & Google", "task": "Add real hyperlinks to the studies mentioned in the text (see Words on the Page).", "why": "Linked, citable sources are one of the strongest signals AI answer engines use to trust and quote medical content.", "priority": "week", "pass": false, "blocker": "asset", "source": "unlinked citations, sections 3-4" }, { "pillar": "Legal & Accessibility Risk", "task": "Add a clear medical disclaimer stating the content is informational, not medical advice, and to consult a prescribing clinician.", "why": "The article discusses medication side effects, mood changes, and a suicidality signal without any visible disclaimer, which is a real legal exposure for this kind of content.", "priority": "week", "pass": false, "blocker": "asset", "source": "no disclaimer visible across sections 1-6" }, { "pillar": "Legal & Accessibility Risk", "task": "Check and increase the contrast of the small green label text ('THE SHORT ANSWER') against the dark green background.", "why": "Light text on a similarly dark background can fail minimum contrast standards, making it hard to read for people with low vision.", "priority": "week", "pass": false, "blocker": null, "source": "label text, section 1 dark callout box" }, { "pillar": "Legal & Accessibility Risk", "task": "Fix the justified-text gaps described above, since they also affect readability for users with dyslexia or low vision.", "why": "Uneven word spacing from justified text is a known accessibility issue, not just a cosmetic one.", "priority": "week", "pass": false, "blocker": null, "source": "WCAG 1.4.8, sections 1-2 callout boxes" }, { "pillar": "Legal & Accessibility Risk", "task": "Confirm the footer (or the 'Legal' nav link) actually contains Privacy Policy, Terms, and an Accessibility statement.", "why": "No dedicated footer with these links is visible anywhere on the page, and relying on a single 'Legal' link may not be enough for a site discussing medication.", "priority": "month", "pass": false, "blocker": "confirm", "source": "no footer legal links visible, section 6" } ], "executive_summary": "This article scores 64/100 today: the writing and structure are genuinely strong (clear headings, a well-organized FAQ, good dates and author byline), but three things are dragging it down. First, two of the highlighted 'short answer' bullets have visible gaps where text appears to be missing, making the page look broken right at the top. Second, this is a health article about medication side effects and a suicidality data signal with no visible medical disclaimer anywhere on the page, which is a real legal risk. Third, the studies referenced by name (Klausen et al., the SELECT trial, FDA/EMA reviews) aren't linked to sources, which weakens both reader trust and how AI tools and Google will rate the content's credibility. Fixing these three issues, plus tightening button styling and text alignment, should bring the page to roughly 85/100." }, { "page": "Blog Orforglipron First Glp1 Pill 2026", "url": "https://ozemback.com/blog/orforglipron-first-glp1-pill-2026", "score_today": 64, "score_after_fixes": 85, "priority_summary": [ { "title": "Add a visible medical disclaimer", "why": "The page discusses prescription drug dosing and comparisons but nowhere tells readers to consult a doctor, which is a real legal exposure for health content." }, { "title": "Replace or caption the mismatched hero photo", "why": "The article is about a daily pill, but the only photo on the page shows glass vials and cork stoppers, not a tablet, so the main image doesn't match the story." }, { "title": "Name a credentialed reviewer and link real trial sources", "why": "Health articles need a named expert and citations to actual studies (ATTAIN-1, ACHIEVE-1) to be trusted by readers, Google, and AI answer engines." } ], "findings": [ { "pillar": "Photos & Images", "task": "Swap the staged vial/cork-stopper photo for an image that actually shows the oral tablet or a clinical/pharmacy setting", "why": "Readers land on an article about 'the first GLP-1 pill' and see labeled glass bottles instead of a pill, which undercuts credibility on a medical topic.", "priority": "week", "pass": false, "blocker": "asset", "source": "content-image mismatch reduces perceived accuracy on YMYL topics" }, { "pillar": "Photos & Images", "task": "Add descriptive alt text to the hero image describing it as a staged/stock photo, not a product photo", "why": "Screen reader users need to know what the image actually shows so they aren't misled about what's pictured.", "priority": "month", "pass": false, "blocker": null, "source": "WCAG 1.1.1 non-text content" }, { "pillar": "Photos & Images", "task": "Keep the soft, warm styling of the hero photo consistent with the site's editorial tone", "why": "The lighting and color palette match the rest of the page nicely and give the brand a calm, trustworthy feel.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Buttons & Actions", "task": "Style the 'Subscribe' nav item as a distinct button instead of a plain text link", "why": "Subscribe is the main action you want readers to take, so it should stand out visually from 'Stories,' 'About,' and 'Legal,' which are just navigation.", "priority": "month", "pass": false, "blocker": null, "source": "primary CTA visual weight" }, { "pillar": "Buttons & Actions", "task": "Add a clear next-step link at the end of the article (e.g. back to Stories or 'read more like this')", "why": "After a 12-minute read, readers are given no obvious next step and may just leave the site.", "priority": "month", "pass": false, "blocker": null, "source": "end-of-content dead end" }, { "pillar": "Buttons & Actions", "task": "Keep the EN/ES language toggle simple and visible in the header", "why": "It's clearly labeled and easy to find, which is good for reaching Spanish-speaking readers.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Layout & Structure", "task": "Add a footer with privacy policy, terms, contact info, and company details after the FAQ", "why": "The page ends abruptly right after the FAQ with no footer at all, even though a 'Legal' link exists in the header, so there's nowhere at the bottom of the page for standard legal/contact info.", "priority": "week", "pass": false, "blocker": "asset", "source": "missing site footer" }, { "pillar": "Layout & Structure", "task": "Continue using the colored callout boxes (dark green 'Short Answer', tan 'Who this is for') to break up long text sections", "why": "These boxes make a long article easier to scan and highlight the most important takeaways.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Layout & Structure", "task": "Maintain the clear serif-headline / sans-body typographic hierarchy used throughout", "why": "Section headers are easy to spot, which helps readers navigate a long article.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Words on the Page", "task": "Add inline citations or a references list linking to the actual ATTAIN-1 and ACHIEVE-1 trial data and FDA filings", "why": "The article states specific percentages (12.4% weight loss, 1.3\u20131.6 point HbA1c drop) with no source link, which weakens trust in the numbers.", "priority": "week", "pass": false, "blocker": "asset", "source": "unsourced statistical claims in health content" }, { "pillar": "Words on the Page", "task": "Replace the generic 'OZEMBACK EDITORIAL' byline with a named author and, ideally, a medical reviewer with credentials", "why": "Health content without a named expert reviewer is harder for readers (and Google) to trust as accurate medical information.", "priority": "week", "pass": false, "blocker": "asset", "source": "E-E-A-T author signals for YMYL content" }, { "pillar": "Words on the Page", "task": "Keep explaining technical concepts (small-molecule vs. peptide) in plain language as done in the 'What orforglipron actually is' section", "why": "This section makes a complex pharmacology distinction easy to understand for a general reader.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Menu & Getting Around", "task": "Add a breadcrumb trail (e.g. Home > Stories > Orforglipron) above the headline", "why": "Readers arriving from search have no visual cue for where this article sits within the site.", "priority": "month", "pass": false, "blocker": null, "source": "missing breadcrumb navigation" }, { "pillar": "Menu & Getting Around", "task": "Add related-article or 'back to Stories' links at the bottom of the page", "why": "Right now the article just stops after the FAQ, giving readers no path to keep browsing the site.", "priority": "month", "pass": false, "blocker": null, "source": "no internal linking at content end" }, { "pillar": "Menu & Getting Around", "task": "Keep the top navigation short and uncluttered (Stories, About, Legal, Subscribe)", "why": "A simple four-item menu is easy to scan and doesn't overwhelm the reader.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Being Found by AI & Google", "task": "Keep the direct Q&A 'Frequently asked' section formatted as clear question-then-answer pairs", "why": "This format is exactly what AI answer engines and Google's featured snippets look for, and it's already done well here.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" }, { "pillar": "Being Found by AI & Google", "task": "Link out to authoritative sources (FDA, ClinicalTrials.gov, journal publications) for the trial data cited", "why": "Outbound links to trusted medical sources boost how much Google and AI models trust and cite this page.", "priority": "week", "pass": false, "blocker": "asset", "source": "outbound authority linking for E-E-A-T" }, { "pillar": "Being Found by AI & Google", "task": "Add a visible author/reviewer bio with medical credentials near the byline", "why": "Search engines and AI systems weigh named expertise heavily for health topics, and right now the byline is just a generic editorial name.", "priority": "week", "pass": false, "blocker": "asset", "source": "author expertise signal for YMYL ranking" }, { "pillar": "Legal & Accessibility Risk", "task": "Add a clear medical disclaimer (e.g. 'This is not medical advice; talk to your doctor before starting or stopping any medication')", "why": "The article compares prescription drug dosing and efficacy without any disclaimer, which is a meaningful legal risk for content discussing medications.", "priority": "week", "pass": false, "blocker": "confirm", "source": "lack of medical disclaimer on drug-comparison content" }, { "pillar": "Legal & Accessibility Risk", "task": "Increase contrast of the yellow-green arrow bullets and small labels against the dark green callout boxes", "why": "Light olive text on dark green may be hard to read for readers with low vision.", "priority": "week", "pass": false, "blocker": null, "source": "WCAG 1.4.3 contrast minimum" }, { "pillar": "Legal & Accessibility Risk", "task": "Darken the small gray byline/date text against the cream background", "why": "Light gray text on an off-white background can fall below readable contrast levels for some readers.", "priority": "month", "pass": false, "blocker": null, "source": "WCAG 1.4.3 contrast minimum" }, { "pillar": "Legal & Accessibility Risk", "task": "Add footer legal links (privacy policy, terms of use, cookie notice) since a 'Legal' nav item exists but no footer is present anywhere on the page", "why": "A completely missing footer means there's no easy, expected place for legal and compliance links, which matters for a site publishing medical content.", "priority": "week", "pass": false, "blocker": "asset", "source": "missing standard footer legal links" }, { "pillar": "Legal & Accessibility Risk", "task": "Continue using clear heading levels (H1 title, H2 sections, H3 subsections) throughout the article", "why": "This structure helps screen reader users jump between sections easily.", "priority": "good", "pass": true, "blocker": null, "source": "n/a" } ], "executive_summary": "This article scores 64/100 today: the writing is clear and well-organized with a strong FAQ section and comparison table, but it has real gaps for a page discussing prescription drug dosing and efficacy. The biggest issues are the complete absence of a medical disclaimer or footer with legal links anywhere on the page, a hero photo of glass vials that doesn't actually depict the pill the article is about, and no named medical reviewer or links to the real clinical trial sources being cited. Fixing these three items \u2014 adding a disclaimer and footer, matching the hero image to the topic, and naming a credentialed reviewer with source links \u2014 would bring the score up to an estimated 85/100 and meaningfully reduce legal and trust risk." }, { "page": "Blog Retatrutide Glp3 What We Know", "url": "https://ozemback.com/blog/retatrutide-glp3-what-we-know", "score_today": 69, "score_after_fixes": 87, "priority_summary": [ { "title": "Swap the hero photo for an accurate one", "why": "Retatrutide is an injectable drug, but the hero photo shows a dropper bottle, which misrepresents the product and undermines trust on a medical topic." }, { "title": "Turn the 'Sources cited' list into real clickable links", "why": "Readers and AI crawlers can't verify a health claim if the studies and investor reports listed at the bottom aren't linked to their actual pages." }, { "title": "Add a named author or medical reviewer with credentials", "why": "Health content with only 'Ozemback Editorial' as the byline looks less trustworthy to readers, Google, and AI answer engines than content signed by a real person with relevant expertise." } ], "findings": [ { "pillar": "Photos & Images", "task": "Replace the dropper-bottle hero photo with an image that matches how retatrutide is actually administered (injectable pen/vial, not a dropper serum)", "why": "Showing the wrong drug format on a medical article damages credibility and could mislead readers about how the product works.", "priority": "week", "pass": false, "blocker": "asset", "source": "hero image, section 1" }, { "pillar": "Photos & Images", "task": "Add cover images to the two book recommendation cards", "why": "Book cards with only text and no cover art look unfinished and get fewer clicks than cards with a visual.", "priority": "month", "pass": false, "blocker": "asset", "source": "Books on the Shelf cards, section 6" }, { "pillar": "Photos & Images", "task": "Confirm the hero photo has descriptive alt text", "why": "Screen reader users need a text description of what the image shows, especially since the image is decorative stock photography rather than informative.", "priority": "month", "pass": false, "blocker": null, "source": "hero , section 1" }, { "pillar": "Buttons & Actions", "task": "Make each entry in 'Sources cited in this article' a clickable link to its source", "why": "Right now the five citations are just bold text with no way to click through and verify them, which weakens trust in the data.", "priority": "week", "pass": false, "blocker": "asset", "source": "Sources cited block, section 5" }, { "pillar": "Buttons & Actions", "task": "Hyperlink the in-body mentions of 'Drugs.com's pipeline page' and 'the Lilly investor relations site'", "why": "The article tells readers to bookmark these pages but doesn't give them a clickable way to get there.", "priority": "week", "pass": false, "blocker": "asset", "source": "'What to actually do, now' list item 3, section 4" }, { "pillar": "Buttons & Actions", "task": "Style the three 'Further Reading' article titles as clear links (underline or arrow)", "why": "As plain dark text they look like headings, not clickable links, so readers may not realize they can click through.", "priority": "month", "pass": false, "blocker": "confirm", "source": "Further Reading list, section 6" }, { "pillar": "Buttons & Actions", "task": "Keep the 'GET THE GUIDE', 'JOIN THE LIST', and 'View on Amazon' buttons as-is", "why": "These are styled distinctly, high-contrast, and clearly clickable.", "priority": "good", "pass": true, "blocker": null, "source": "header CTA, newsletter CTA, book cards" }, { "pillar": "Layout & Structure", "task": "Add a short jump-to-section list near the top using the existing headings (Naming, Data, Timeline, What to do)", "why": "This is a long 9-minute article; letting readers jump to the part they care about keeps them from bouncing.", "priority": "month", "pass": false, "blocker": null, "source": "H2 structure across sections 2-4" }, { "pillar": "Layout & Structure", "task": "Keep the consistent callout-box style (TL;DR, editorial caution, pull quote) with the left green accent bar", "why": "Repeating the same visual treatment for asides makes the page easy to scan.", "priority": "good", "pass": true, "blocker": null, "source": "TL;DR box section 2, caution box section 4, quote block section 3" }, { "pillar": "Layout & Structure", "task": "Keep the three-stat row (29%, 71.2, 7+) as a simple, scannable summary", "why": "Large numbers with short labels are an easy way to communicate the key data points at a glance.", "priority": "good", "pass": true, "blocker": null, "source": "stat row, section 3" }, { "pillar": "Words on the Page", "task": "Add a named author or medically-reviewed-by credit near the byline", "why": "For health content, readers and search engines trust a real name and credentials more than an anonymous editorial team.", "priority": "week", "pass": false, "blocker": "asset", "source": "byline 'OZEMBACK EDITORIAL', section 1" }, { "pillar": "Words on the Page", "task": "Keep the repeated hedging language ('investigational,' 'not yet approved,' 'averages vary')", "why": "This kind of careful, honest wording is exactly what regulators and readers expect from medical content.", "priority": "good", "pass": true, "blocker": null, "source": "body copy, sections 2-3" }, { "pillar": "Words on the Page", "task": "Keep the TL;DR summary box near the top", "why": "It gives readers (and AI tools scanning the page) a fast, accurate summary of the whole article.", "priority": "good", "pass": true, "blocker": null, "source": "TL;DR box, section 2" }, { "pillar": "Menu & Getting Around", "task": "Add a simple text breadcrumb (Home > Journal > Retatrutide) above the headline", "why": "A breadcrumb helps readers understand where they are in the site and makes it easy to back out to the full journal.", "priority": "month", "pass": false, "blocker": null, "source": "top of article, section 1" }, { "pillar": "Menu & Getting Around", "task": "Keep matching navigation links in both the header and footer", "why": "Having the same core links (Map, Guide, Journal) in both places makes the site easy to navigate from anywhere on the page.", "priority": "good", "pass": true, "blocker": null, "source": "header nav section 1, footer nav section 6" }, { "pillar": "Being Found by AI & Google", "task": "Hyperlink every source in the citations list to its real source page", "why": "Search engines and AI tools reward health content that clearly links to verifiable primary sources; unlinked citations look unverified.", "priority": "week", "pass": false, "blocker": "asset", "source": "Sources cited block, section 5" }, { "pillar": "Being Found by AI & Google", "task": "Add visible author credentials or a medical reviewer line", "why": "Google's guidance for health topics puts heavy weight on who wrote or reviewed the content; an anonymous 'Editorial' byline is a weak signal.", "priority": "week", "pass": false, "blocker": "asset", "source": "byline, section 1" }, { "pillar": "Being Found by AI & Google", "task": "Keep the clear dated bylines ('April 2026', 'Updated Q2 2026') and structured H2s", "why": "Visible freshness dates and clean headings help both search engines and AI summarizers understand and trust the content.", "priority": "good", "pass": true, "blocker": null, "source": "byline and H2 structure, sections 1-4" }, { "pillar": "Legal & Accessibility Risk", "task": "Add a named, credentialed medical reviewer or author bio", "why": "For content making direct drug efficacy comparisons, an anonymous byline increases legal and reputational risk if claims are ever challenged.", "priority": "week", "pass": false, "blocker": "asset", "source": "byline, section 1" }, { "pillar": "Legal & Accessibility Risk", "task": "Check the orange link color against the cream background for contrast", "why": "Light orange text on a light cream background may not meet accessibility contrast standards for readers with low vision.", "priority": "week", "pass": false, "blocker": null, "source": "orange hyperlinks, sections 4-5" }, { "pillar": "Legal & Accessibility Risk", "task": "Keep the full medical disclaimer and 'not affiliated with Lilly/Novo Nordisk' trademark notice in the footer", "why": "This is exactly the kind of disclosure regulated health content needs, and it's already clearly present.", "priority": "good", "pass": true, "blocker": null, "source": "Medical Disclaimer block and footer trademark text, sections 5-6" }, { "pillar": "Legal & Accessibility Risk", "task": "Keep the Amazon affiliate disclosure text under the book cards", "why": "Disclosing paid affiliate relationships is required and is already handled clearly here.", "priority": "good", "pass": true, "blocker": null, "source": "affiliate disclosure text, section 6" } ], "executive_summary": "This retatrutide article scores about 69/100: the writing is careful and well-organized with good disclaimers, but three things are holding it back from being fully trustworthy as health content. First, the hero photo shows a dropper bottle even though the drug is actually injectable, which is a mismatch that can confuse or mislead readers. Second, the 'Sources cited' list at the bottom names real studies and reports but doesn't link to any of them, so nobody can click through to verify the claims. Third, the article has no named author or medical reviewer, just 'Ozemback Editorial,' which weakens trust for both readers and search engines on a medical topic. Fixing the image, linking the sources, and adding a real byline with credentials would push this page to roughly 87/100." }, { "page": "Blog Fda Peptide Reclassification 2026", "url": "https://ozemback.com/blog/fda-peptide-reclassification-2026", "score_today": 74, "score_after_fixes": 89, "priority_summary": [ { "title": "Put a real disclaimer inside the article, not just a nav link", "why": "This is health/regulatory content about FDA drug rules and peptide legality, so readers need a clear caution right in the story, not buried in a menu item." }, { "title": "Add a jump-to-section outline near the top", "why": "It's a 9-minute read with 8+ sections and no way to skip to the part a reader actually needs, like the July 23 meeting or the FAQ." }, { "title": "Give readers a next step partway through the article", "why": "The only clickable action on the whole page is the 'Free Guide' button in the header, so a long, engaged reader has nothing to click until they scroll all the way back up." } ], "findings": [ { "pillar": "Photos & Images", "task": "Add descriptive alt text to the hero photo of the bottle and pen", "why": "Screen reader users and Google both need a text description of what the image shows.", "priority": "week", "pass": false, "blocker": null, "source": "WCAG 1.1.1 non-text content" }, { "pillar": "Photos & Images", "task": "Add a small author photo or avatar next to the byline", "why": "A face next to 'Ozemback Editorial' makes the article feel more trustworthy, especially for medical/regulatory content.", "priority": "month", "pass": false, "blocker": "asset", "source": "E-E-A-T trust signals for YMYL content" }, { "pillar": "Photos & Images", "task": "Add a thumbnail image to each 'Keep reading' card", "why": "The three related-article cards are currently text-only, which makes them easy to skip past.", "priority": "month", "pass": false, "blocker": "asset", "source": "visual scanning / recognition over recall" }, { "pillar": "Photos & Images", "task": "Hero photo tone matches the editorial, regulatory subject well", "why": "A moody, considered photo (bottle, pen, paper) fits a legal/regulatory story better than a generic stock shot.", "priority": "good", "pass": true, "blocker": null, "source": "brand-content fit" }, { "pillar": "Buttons & Actions", "task": "Add one clear call-to-action inside the article body (e.g. link to a Paid Guide or the Free Guide)", "why": "Right now a reader has to scroll all the way back to the top header to take any action after reading 9 minutes of content.", "priority": "week", "pass": false, "blocker": null, "source": "conversion path / calls-to-action per scroll depth" }, { "pillar": "Buttons & Actions", "task": "Make the 'Keep reading' cards look more clickable (e.g. add a visible arrow or underline on the title)", "why": "As shown, they read like plain text blocks rather than obvious links.", "priority": "month", "pass": false, "blocker": null, "source": "affordance cues for interactive elements" }, { "pillar": "Buttons & Actions", "task": "Header 'Free Guide' button stands out clearly with good color contrast and consistent placement", "why": "It's easy to spot on every scroll position since it's in the fixed header.", "priority": "good", "pass": true, "blocker": null, "source": "consistent primary CTA placement" }, { "pillar": "Layout & Structure", "task": "Add a short jump-to-section list (using the existing H2 headings) near the top of the article", "why": "Readers skimming a long regulatory piece need to jump straight to 'July 23 meeting' or 'FAQ' without scrolling through everything.", "priority": "week", "pass": false, "blocker": null, "source": "long-form content navigation aids" }, { "pillar": "Layout & Structure", "task": "Add a breadcrumb trail above the headline (Home > Journal > Article)", "why": "It orients readers to where they are in the site and gives them an easy way back.", "priority": "month", "pass": false, "blocker": null, "source": "breadcrumb navigation for content hierarchy" }, { "pillar": "Layout & Structure", "task": "TL;DR and Important callout boxes visually separate summary and warning content from the main body", "why": "This lets readers get the key facts even if they don't read the whole piece.", "priority": "good", "pass": true, "blocker": null, "source": "content chunking for scannability" }, { "pillar": "Words on the Page", "task": "Add a one- or two-line disclaimer directly in the article body (e.g. right after the intro paragraph)", "why": "The article discusses drug legality and dosing pathways; a visible reminder that this isn't medical/legal advice belongs in the story itself.", "priority": "week", "pass": false, "blocker": null, "source": "YMYL content disclosure best practice" }, { "pillar": "Words on the Page", "task": "Replace generic 'Ozemback Editorial' byline with a named author and their credentials", "why": "Google and readers trust health-adjacent content more when a real, qualified person is attached to it.", "priority": "month", "pass": false, "blocker": "asset", "source": "E-E-A-T author expertise signals" }, { "pillar": "Words on the Page", "task": "TL;DR summary and FAQ format make dense regulatory content easy to digest quickly", "why": "Busy readers get the core answer ('not legal yet, meeting July 23') without reading the full piece.", "priority": "good", "pass": true, "blocker": null, "source": "front-loaded summary pattern" }, { "pillar": "Menu & Getting Around", "task": "Style the Sources & References links (and any other real links) so they look different from bold body text", "why": "Right now bold citation text looks the same as bold emphasis elsewhere, so readers can't tell what's clickable.", "priority": "month", "pass": false, "blocker": null, "source": "link affordance / discoverability" }, { "pillar": "Menu & Getting Around", "task": "Add anchor links from each FAQ question straight down to its own answer", "why": "Helps readers who arrive from a search result looking for one specific question jump right to it.", "priority": "good", "pass": false, "blocker": null, "source": "in-page anchor navigation" }, { "pillar": "Menu & Getting Around", "task": "Top navigation is short, clearly labeled, and consistent (Peptides, Journal, Paid Guides, Disclaimer)", "why": "A small, clear menu keeps visitors from getting lost.", "priority": "good", "pass": true, "blocker": null, "source": "minimal, task-focused navigation" }, { "pillar": "Being Found by AI & Google", "task": "Confirm the FAQ section is marked up as structured FAQ data", "why": "This content is already formatted as clean Q&A, which is exactly what Google and AI answer engines look for to feature it directly in results.", "priority": "week", "pass": false, "blocker": "confirm", "source": "FAQPage schema for rich results" }, { "pillar": "Being Found by AI & Google", "task": "Add author credentials/bio block to strengthen the page's trust signals for search and AI citation", "why": "Named expertise on regulatory health content makes it more likely to be cited as a trustworthy source.", "priority": "month", "pass": false, "blocker": "asset", "source": "author-level E-E-A-T signals" }, { "pillar": "Being Found by AI & Google", "task": "Specific dates, named agencies (HHS, FDA), and a Sources & References list make this article highly citable", "why": "This is exactly the kind of concrete, sourced detail that search engines and AI tools prefer to quote.", "priority": "good", "pass": true, "blocker": null, "source": "citation-worthy content structure" }, { "pillar": "Legal & Accessibility Risk", "task": "Add a visible disclaimer inside the article body given the subject is FDA drug classification and compounding legality", "why": "Relying on a separate nav 'Disclaimer' page is a weaker legal protection than a disclaimer readers actually see while reading claims about drug legality.", "priority": "week", "pass": false, "blocker": null, "source": "health/legal content disclosure risk" }, { "pillar": "Legal & Accessibility Risk", "task": "Check color contrast on the orange/terracotta italic headline text and the pale green text inside the dark decorative divider band", "why": "Both of those color combinations look like they could fall short of readable contrast for users with low vision.", "priority": "week", "pass": false, "blocker": null, "source": "WCAG 1.4.3 contrast minimum" }, { "pillar": "Legal & Accessibility Risk", "task": "The 'Important' callout clearly states that an HHS announcement is not yet an FDA rule", "why": "This directly reduces the risk of readers assuming these peptides are already legal, which matters a lot for a regulated-substance topic.", "priority": "good", "pass": true, "blocker": null, "source": "clear disclosure of regulatory status" } ], "executive_summary": "This long-form article scores 74/100 today \u2014 the writing, TL;DR summary, callout boxes, FAQ, and sourced references are genuinely well done for a regulatory topic, but three gaps hold it back: there's no disclaimer visible inside the article itself even though it covers FDA drug legality (only a nav link), there's no way to jump to a specific section in a 9-minute read, and there's no call-to-action anywhere in the body so engaged readers hit a dead end until they scroll back to the header. Fixing these three plus tightening up author credentials and link/color contrast would bring this to an estimated 89/100, all without needing to build any new page sections." }, { "page": "Legal", "url": "https://ozemback.com/legal", "score_today": 71, "score_after_fixes": 89, "priority_summary": [ { "title": "Fix low-contrast orange text in the callout box", "why": "The orange/red disclaimer text on the tan background is hard to read for many people and is the most legally important content on the page." }, { "title": "Add jump links to the long legal document", "why": "The page has 15+ sections and no way to jump to a specific one, so readers (and their lawyers) have to scroll through the whole thing to find one clause." }, { "title": "Turn 'Subscribe' into a real button", "why": "It currently looks like every other plain text nav link, so the site's main growth action barely stands out." } ], "findings": [ { "pillar": "Photos & Images", "task": "Keep this page text-only / image-light", "why": "A legal disclaimer doesn't need photos, and the current bare-bones layout keeps the focus on the important text.", "priority": "good", "pass": true, "blocker": null, "source": "content hierarchy" }, { "pillar": "Photos & Images", "task": "Confirm the small logo icon has descriptive alt text", "why": "Screen reader users need to know this icon represents the Ozemback brand mark, not just a decorative circle.", "priority": "month", "pass": false, "blocker": null, "source": "img alt attribute" }, { "pillar": "Buttons & Actions", "task": "Style 'SUBSCRIBE' as a distinct button, not a plain nav link", "why": "It's the site's main conversion action but visually blends in with informational links like Stories and About.", "priority": "week", "pass": false, "blocker": null, "source": "visual hierarchy / primary CTA affordance" }, { "pillar": "Buttons & Actions", "task": "Add a small 'Subscribe to the newsletter' link near the Contact section", "why": "The page mentions a monthly newsletter twice but gives readers no easy way to act on it right there.", "priority": "month", "pass": false, "blocker": null, "source": "call-to-action placement" }, { "pillar": "Buttons & Actions", "task": "Make the mailto email links visually match other clickable elements", "why": "Right now the only interactive elements on the page are text-colored links, so people may not realize they're clickable.", "priority": "good", "pass": true, "blocker": null, "source": "link affordance consistency" }, { "pillar": "Layout & Structure", "task": "Add anchor/jump links for each section heading (What Ozemback does, References, Editorial standards, etc.)", "why": "The page is very long with 15+ headings and no way to skip straight to the one you need.", "priority": "week", "pass": false, "blocker": null, "source": "long-document in-page navigation" }, { "pillar": "Layout & Structure", "task": "Keep the red vertical accent bar highlighting the core disclaimer", "why": "It clearly visually separates the single most important legal statement from the rest of the page.", "priority": "good", "pass": true, "blocker": null, "source": "visual emphasis pattern" }, { "pillar": "Layout & Structure", "task": "Consistent heading hierarchy throughout (Legal & Disclaimer > section headers > body)", "why": "This makes the document easy to scan and is good for both readers and screen readers.", "priority": "good", "pass": true, "blocker": null, "source": "heading structure" }, { "pillar": "Words on the Page", "task": "Keep the plain-language explanations of what the site does/does not do", "why": "Turning legal boilerplate into a simple bulleted list is genuinely reader-friendly and reduces confusion.", "priority": "good", "pass": true, "blocker": null, "source": "plain-language legal writing" }, { "pillar": "Words on the Page", "task": "Double check the 'LAST UPDATED: MAY 2026' date is correct", "why": "A future-dated 'last updated' stamp can look like an error and undermine trust in the document's accuracy.", "priority": "month", "pass": false, "blocker": "confirm", "source": "content accuracy check" }, { "pillar": "Words on the Page", "task": "Continue citing sources and years for regulatory/scientific claims", "why": "This is already being done and builds credibility for a site writing about medical topics.", "priority": "good", "pass": true, "blocker": null, "source": "sourcing transparency" }, { "pillar": "Menu & Getting Around", "task": "Keep the matching header and footer navigation", "why": "Having the same core links (Stories, About, Legal) in both places makes the site easy to navigate from anywhere.", "priority": "good", "pass": true, "blocker": null, "source": "nav consistency" }, { "pillar": "Menu & Getting Around", "task": "Add a short table of contents near the top of this legal page", "why": "With this many sections, a simple list of links at the top would save readers a lot of scrolling.", "priority": "week", "pass": false, "blocker": null, "source": "in-page navigation for long content" }, { "pillar": "Menu & Getting Around", "task": "Add a visible 'Privacy Policy' or 'Cookie Policy' footer link if one exists separately", "why": "Currently only 'Legal & Disclaimer' is listed, so shoppers can't tell if privacy terms are covered elsewhere or bundled here.", "priority": "month", "pass": false, "blocker": "confirm", "source": "footer link completeness" }, { "pillar": "Being Found by AI & Google", "task": "Keep the clear, descriptive page title 'Legal & Disclaimer'", "why": "This helps both users and search engines immediately understand the page's purpose.", "priority": "good", "pass": true, "blocker": null, "source": "page title clarity" }, { "pillar": "Being Found by AI & Google", "task": "Add hreflang tags to support the EN/ES language toggle", "why": "Without this, Google may not correctly show Spanish-speaking users the Spanish version in search results.", "priority": "month", "pass": false, "blocker": "confirm", "source": "international SEO / hreflang" }, { "pillar": "Being Found by AI & Google", "task": "Add a meta description summarizing this is a legal/medical disclaimer for a cultural magazine", "why": "A good meta description improves how this page appears in Google search results and AI answer summaries.", "priority": "month", "pass": false, "blocker": null, "source": "meta description / snippet optimization" }, { "pillar": "Legal & Accessibility Risk", "task": "Increase contrast of the orange/red highlighted text against the tan callout background", "why": "This color combination likely fails accessibility contrast standards, making the most critical disclaimer text hard to read for many people.", "priority": "week", "pass": false, "blocker": null, "source": "WCAG 2.1 AA contrast ratio (4.5:1)" }, { "pillar": "Legal & Accessibility Risk", "task": "Add a visible cookie consent notice if any tracking/analytics is used", "why": "None of the four page sections show a cookie banner, which is a compliance gap if the site collects data from EU or other regulated visitors.", "priority": "week", "pass": false, "blocker": "confirm", "source": "cookie consent / GDPR-style compliance" }, { "pillar": "Legal & Accessibility Risk", "task": "Keep the thorough disclaimer covering medical advice, liability, indemnification, and governing law", "why": "This is a strong, complete legal disclaimer for a magazine writing about medications \u2014 better than most sites in this space.", "priority": "good", "pass": true, "blocker": null, "source": "legal disclaimer completeness" }, { "pillar": "Legal & Accessibility Risk", "task": "Add a skip-to-content link for keyboard and screen reader users", "why": "None is visible across any part of the page, and it would help users skip the repeated navigation on such a long page.", "priority": "month", "pass": false, "blocker": null, "source": "WCAG 2.4.1 bypass blocks" } ], "executive_summary": "This legal disclaimer page scores 71/100 today \u2014 the actual legal writing is thorough and clearly worded, which is a real strength for a site discussing weight-loss medications. The biggest issues are practical, not legal: the highlighted orange disclaimer text likely doesn't meet contrast/readability standards, the page has no jump links despite being extremely long (15+ sections), and the 'Subscribe' button in the navigation looks identical to plain informational links, quietly hurting newsletter growth. There's also no visible cookie consent notice, which is worth a quick compliance check given the bilingual (EN/ES) audience. None of these fixes require new content or design elements \u2014 mostly restyling, adding anchor links, and a quick legal review \u2014 and doing them would bring the score up to an estimated 89/100." } ] }